Related Experiment Video
Updated: May 29, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML)
1Hematology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, 5 Place d'Arsonval, 69437, Lyon Cedex 03, France. mauricette.michallet@chu-lyon.fr
Abstract:
Invasive aspergillosis (IA) during induction chemotherapy of acute myeloid leukemia (AML) could worsen the prognosis. Our objective was to study how the development of IA during AML interferes with the therapeutic strategy and to evaluate its impact on the short- and long-term survival. Newly diagnosed AML patients between the years 2004 and 2007 were retrospectively analyzed. The outcome was death of the patient. A Cox proportional hazards model with the diagnosis of IA and post-induction response evaluation as the main exposure was fitted. Overall, 262 patients were analyzed and 58 IA were observed. The 2-year survival of patients having had remission of AML was 54% and, for patients with failure of chemotherapy, it was 5% (p < 0.001). The 2-year survival of patients having had IA was 14%, and without IA, it was 32% (p = 0.01). Multivariate analysis showed that IA was associated with a higher risk of death in case of remission compared to no IA (hazard ratio [HR] = 1.66 [1.05-2.65], p = 0.031) and also in case of failure (HR = 6.43, p < 0.001). IA was associated with an increased risk of death for patients if they were either in remission or in failure after induction chemotherapy.
Insights
Invasive aspergillosis (IA) significantly increases mortality risk in acute myeloid leukemia (AML) patients undergoing induction chemotherapy. This fungal infection drastically reduces survival rates, regardless of treatment response.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Invasive aspergillosis (IA) poses a significant threat during induction chemotherapy for acute myeloid leukemia (AML).
- IA can complicate treatment strategies and negatively impact patient prognosis.
Purpose of the Study:
- To investigate how IA development affects AML therapeutic strategies.
- To evaluate the short- and long-term survival impact of IA in AML patients.
Main Methods:
- Retrospective analysis of newly diagnosed AML patients (2004-2007).
- Cox proportional hazards model used to assess the impact of IA diagnosis and treatment response on survival.
- 262 patients analyzed; 58 cases of IA observed.
Main Results:
- Two-year survival was 54% for AML remission patients versus 5% for chemotherapy failure patients (p < 0.001).
- Two-year survival was 14% for patients with IA versus 32% for patients without IA (p = 0.01).
- Multivariate analysis revealed IA significantly increased death risk in both remission (HR=1.66) and failure (HR=6.43) groups.
Conclusions:
- IA is associated with a substantially increased risk of death in AML patients.
- The negative survival impact of IA persists irrespective of remission or chemotherapy failure status.
Related Concept Videos
Cryptococcal Meningitis
Amebiasis
Fungal Phylum Ascomycota
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
